# Pulse Biosciences, Inc.: Form 8-K, filed Apr 7, 2026

- Company: [Pulse Biosciences, Inc.](/companies/plse.md) (CIK 1625101)
- Form: 8-K
- Filed: 2026-04-07
- Accepted by EDGAR: Apr 7, 2026, 08:59 ET
- Period: 2026-04-07
- Accession: 0001437749-26-011546
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1625101/000143774926011546/plse20260406_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1625101/000143774926011546/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1625101/000143774926011546/plse20260406_8k.htm

Filed Apr 7, 2026.
Source: SEC EDGAR, the filing index for accession 0001437749-26-011546. Last ingested by Listed: Nov 6, 2026, 12:23 ET. No prices; not investment advice.